Literature DB >> 17057725

Regulating regulatory T cells.

N T Le1, N Chao.   

Abstract

Regulatory T cells (Tregs) are a specialized subpopulation of T cells that act to suppress activation of other immune cells and thereby maintain immune system homeostasis, self-tolerance as well as control excessive response to foreign antigens. The mere concept of Tregs was the subject of significant controversy among immunologists for many years owing to the paucity of reliable markers for defining these cells and the ambiguity of the nature and molecular basis of suppressive phenomena. However, recent advances in the molecular characterization of this cell population have firmly established their existence and their vital role in the vertebrate immune system. Of interest, accumulating evidence from both humans and experimental animal models has implicated the involvement of Tregs in the development of graft-versus-host disease (GVHD). The demonstration that Tregs could separate GVHD from graft-versus-tumor (GVT) activity suggests that their immunosuppressive potential could be manipulated to reduce GVHD without detrimental consequence on GVT effect. Although a variety of T lymphocytes with suppressive capabilities have been reported, the two best-characterized subsets are the naturally arising, intrathymic-generated Tregs (natural Tregs) and the peripherally generated, inducible Tregs (inducible Tregs). This review summarizes our current knowledge of the generation, function and regulation of these two populations of Tregs during an immune response. Their role in the development of GVHD and their therapeutic potential for the prevention and treatment of GVHD will also be described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057725     DOI: 10.1038/sj.bmt.1705529

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

1.  Reconstitution of regulatory T cells after autologous transplantation in multiple myeloma.

Authors:  Prasanth Ganeshan; Ritu Gupta; Mrinali Hakim; Lalit Kumar; Archana Bhaskar; Atul Sharma
Journal:  Int J Hematol       Date:  2011-11-03       Impact factor: 2.490

2.  Origins and functional basis of regulatory CD11c+CD8+ T cells.

Authors:  Dass S Vinay; Chang H Kim; Beom K Choi; Byoung S Kwon
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

3.  Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC.

Authors:  Kendra N Taylor; Monika Laszkowska; Evan Cohick; Yolonda L Colson
Journal:  Cell Immunol       Date:  2008-05-23       Impact factor: 4.868

4.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

5.  Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.

Authors:  Meagan J Bemer; Linda J Risler; Brian R Phillips; Joanne Wang; Barry E Storer; Brenda M Sandmaier; Haichuan Duan; Brianne S Raccor; Michael J Boeckh; Jeannine S McCune
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-09       Impact factor: 5.742

6.  Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases.

Authors:  Paolo Perseghin
Journal:  Transfus Med Hemother       Date:  2007-12-21       Impact factor: 3.747

Review 7.  Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Authors:  Robert R Jenq; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

Review 8.  The balance between immunity and tolerance: the role of Langerhans cells.

Authors:  K Mutyambizi; C L Berger; R L Edelson
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

9.  Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation.

Authors:  Minjeong Nam; Sue Shin; Kyoung Un Park; Inho Kim; Sung Soo Yoon; Tack Kyun Kwon; Eun Young Song
Journal:  Ann Lab Med       Date:  2018-11       Impact factor: 3.464

10.  Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin.

Authors:  María Victoria Legorreta-Haquet; Karina Chávez-Rueda; Luis Chávez-Sánchez; Hernando Cervera-Castillo; Edgar Zenteno-Galindo; Leonor Barile-Fabris; Rubén Burgos-Vargas; Everardo Álvarez-Hernández; Francisco Blanco-Favela
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.